GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kainos Medicine Inc (XKRX:284620) » Definitions » Marketable Securities

Kainos Medicine (XKRX:284620) Marketable Securities : ₩0.0 Mil (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Kainos Medicine Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Kainos Medicine's Marketable Securities for the quarter that ended in Jun. 2024 was ₩0.0 Mil.

Kainos Medicine's annual Marketable Securities declined from Dec. 2021 (₩11,000.0 Mil) to Dec. 2022 (₩5,000.0 Mil) and declined from Dec. 2022 (₩5,000.0 Mil) to Dec. 2023 (₩79.8 Mil).


Kainos Medicine Marketable Securities Historical Data

The historical data trend for Kainos Medicine's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kainos Medicine Marketable Securities Chart

Kainos Medicine Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial - 7,860.40 11,000.00 5,000.00 79.85

Kainos Medicine Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 79.85 - -

Kainos Medicine Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Kainos Medicine  (XKRX:284620) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Kainos Medicine Marketable Securities Related Terms

Thank you for viewing the detailed overview of Kainos Medicine's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Kainos Medicine Business Description

Traded in Other Exchanges
N/A
Address
16, Daewangpangyo-ro 712 beon-gil, 4th Floor, Institut Pasteur Korea, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13488
Kainos Medicine Inc conducts research and develops medicines used to treat brain diseases, cancers, and infectious diseases.

Kainos Medicine Headlines

No Headlines